Cite
Approval of modified-release products by FDA without clinical efficacy/safety studies: A retrospective survey from 2008 to 2017.
MLA
Wang, Yi-Lin, et al. “Approval of Modified-Release Products by FDA without Clinical Efficacy/Safety Studies: A Retrospective Survey from 2008 to 2017.” Regulatory Toxicology & Pharmacology: RTP, vol. 103, Apr. 2019, pp. 174–80. EBSCOhost, https://doi.org/10.1016/j.yrtph.2019.01.037.
APA
Wang, Y.-L., Chang, Y.-T., Yang, S.-Y., Chang, Y.-W., Kuan, M.-H., Tu, C.-L., Hong, H.-C., Lai, I.-C., Gau, C.-S., & Hsu, L.-F. (2019). Approval of modified-release products by FDA without clinical efficacy/safety studies: A retrospective survey from 2008 to 2017. Regulatory Toxicology & Pharmacology: RTP, 103, 174–180. https://doi.org/10.1016/j.yrtph.2019.01.037
Chicago
Wang, Yi-Lin, Yi-Ting Chang, Shih-Ying Yang, Ya-Wen Chang, Mei-Hsien Kuan, Chien-Lung Tu, Hui-Chun Hong, I-Chun Lai, Churn-Shiouh Gau, and Li-Feng Hsu. 2019. “Approval of Modified-Release Products by FDA without Clinical Efficacy/Safety Studies: A Retrospective Survey from 2008 to 2017.” Regulatory Toxicology & Pharmacology: RTP 103 (April): 174–80. doi:10.1016/j.yrtph.2019.01.037.